PGAM1 Suppression Sensitizes Tumors to Olaparib (IMAGE)

Rockefeller University Press

PGAM1 Suppression Sensitizes Tumors to Olaparib

Caption

In tumors formed by human breast cancer cells, DNA damage (brown staining) is increased by simultaneous Olaparib treatment and PGAM1 suppression (right) when compared to either Olaparib treatment (left) or PGAM1 suppression (center) alone.

Credit

Qu et al., 2017

Usage Restrictions

Reporters may freely use these materials in news coverage with the appropriate credit information.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.